Comprehensive molecular portraits of human breast tumours<\/title><secondary-title>Nature<\/secondary-title><\/titles><dates><year>2012<\/year><\/dates><electronic-resource-num>10.1038\/nature11412<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.nature.com\/articles\/nature11412.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Boris T. Bikbov<\/author><author>Caroline A. Purcell<\/author><author>Andrew S. Levey et al.<\/author><\/authors><\/contributors><titles><title>Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017<\/title><secondary-title>The Lancet<\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.1016\/s0140-6736(20)30045-3<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.thelancet.com\/pdfs\/journals\/lancet\/PIIS0140-6736(20)30045-3.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Michel Bazinet<\/author><author>Victor P\u00e2ntea<\/author><author>Valentin Cebotarescu et al.<\/author><\/authors><\/contributors><titles><title>Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial<\/title><secondary-title>\u0098The \u009cLancet. Gastroenterology & hepatology<\/secondary-title><\/titles><dates><year>2017<\/year><\/dates><electronic-resource-num>10.1016\/s2468-1253(17)30288-1<\/electronic-resource-num><urls><related-urls><url>https:\/\/ibn.idsi.md\/vizualizare_articol\/56691<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>http:\/\/ljournal.ru\/wp-content\/uploads\/2017\/03\/a-2017-023.pdf<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2017<\/year><\/dates><electronic-resource-num>10.18411\/a-2017-023<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.18411\/a-2017-023<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Marissa Giustina<\/author><author>Marijn A. M. Versteegh<\/author><author>S\u00f6ren Wengerowsky et al.<\/author><\/authors><\/contributors><titles><title>Significant-Loophole-Free Test of Bell\u2019s Theorem with Entangled Photons<\/title><secondary-title>Physical Review Letters<\/secondary-title><\/titles><dates><year>2015<\/year><\/dates><electronic-resource-num>10.1103\/physrevlett.115.250401<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.1103\/physrevlett.115.250401<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Joppe W. Bos<\/author><author>L\u00e9o Ducas<\/author><author>Eike Kiltz et al.<\/author><\/authors><\/contributors><titles><title>CRYSTALS - Kyber: A CCA-Secure Module-Lattice-Based KEM<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1109\/eurosp.2018.00032<\/electronic-resource-num><urls><related-urls><url>https:\/\/ir.cwi.nl\/pub\/27896\/27896.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Annika Rosengren<\/author><author>Andrew Smyth<\/author><author>Sumathy Rangarajan et al.<\/author><\/authors><\/contributors><titles><title>Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study<\/title><secondary-title>The Lancet Global Health<\/secondary-title><\/titles><dates><year>2019<\/year><\/dates><electronic-resource-num>10.1016\/s2214-109x(19)30045-2<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.thelancet.com\/article\/S2214109X19300452\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Kyle J Foreman<\/author><author>Neal Marquez<\/author><author>Andrew J. Dolgert et al.<\/author><\/authors><\/contributors><titles><title>Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016\u201340 for 195 countries and territories<\/title><secondary-title>The Lancet<\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1016\/s0140-6736(18)31694-5<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.thelancet.com\/article\/S0140673618316945\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>The Cancer Genome Atlas Research Network<\/author><\/authors><\/contributors><titles><title>Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas<\/title><secondary-title>New England Journal of Medicine<\/secondary-title><\/titles><dates><year>2015<\/year><\/dates><electronic-resource-num>10.1056\/nejmoa1402121<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa1402121?articleTools=true<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Peter K\u00e4mpfer<\/author><author>P. D. Rekha<\/author><author>Peter Sch\u00fcmann et al.<\/author><\/authors><\/contributors><titles><title>Microbacterium arthrosphaerae sp. nov., isolated from the faeces of the pill millipede Arthrosphaera magna Attems<\/title><secondary-title>INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY<\/secondary-title><\/titles><dates><year>2010<\/year><\/dates><electronic-resource-num>10.1099\/ijs.0.026401-0<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Gregory M. Chin<\/author><author>Anne M. Villeneuve<\/author><\/authors><\/contributors><titles><title>C. elegans mre-11 is required for meiotic recombination and DNA repair but is dispensable for the meiotic G2 DNA damage checkpoint<\/title><secondary-title>Genes & Development<\/secondary-title><\/titles><dates><year>2001<\/year><\/dates><electronic-resource-num>10.1101\/gad.864101<\/electronic-resource-num><urls><related-urls><url>http:\/\/genesdev.cshlp.org\/content\/15\/5\/522.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Jake E. Thistle<\/author><author>Jessica L. Petrick<\/author><author>Baiyu Yang et al.<\/author><\/authors><\/contributors><titles><title>Domperidone use and risk of primary liver cancer in the Clinical Practice Research Datalink<\/title><secondary-title>Cancer Epidemiology<\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1016\/j.canep.2018.06.009<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/7008444<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Cullen T<\/author><author>Mullins J<\/author><author>Rambaud CT et al.<\/author><\/authors><\/contributors><titles><title>Making Vaccines Equitably Available to All Persons in Pima County, Arizona, 2020-2021.<\/title><secondary-title>American journal of public health<\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.2105\/AJPH.2022.307040<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/9558202<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Kusuhara M<\/author><\/authors><\/contributors><titles><title>[Sporotrichosis and dematiaceous fungal skin infections].<\/title><secondary-title>Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology<\/secondary-title><\/titles><dates><year>2009<\/year><\/dates><electronic-resource-num>10.3314\/jjmm.50.213<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.jstage.jst.go.jp\/article\/jjmm\/50\/4\/50_4_213\/_pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Aaseth J<\/author><author>Nurchi VM<\/author><author>Andersen O<\/author><\/authors><\/contributors><titles><title>Medical Therapy of Patients Contaminated with Radioactive Cesium or Iodine.<\/title><secondary-title>Biomolecules<\/secondary-title><\/titles><dates><year>2019<\/year><\/dates><electronic-resource-num>10.3390\/biom9120856<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.mdpi.com\/2218-273X\/9\/12\/856\/pdf?version=1576062311<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Angermayr L<\/author><author>Clar C<\/author><\/authors><\/contributors><titles><title>WITHDRAWN: Iodine supplementation for preventing iodine deficiency disorders in children.<\/title><secondary-title>The Cochrane database of systematic reviews<\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1002\/14651858.CD003819.pub3<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003819.pub3\/pdf\/full<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Burch HB<\/author><author>Cooper DS<\/author><\/authors><\/contributors><titles><title>Management of Graves Disease: A Review.<\/title><secondary-title>JAMA<\/secondary-title><\/titles><dates><year>2015<\/year><\/dates><electronic-resource-num>10.1001\/jama.2015.16535<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Raal A<\/author><author>Meos A<\/author><author>Hinrikus T et al.<\/author><\/authors><\/contributors><titles><title>Dragendorff's reagent: Historical perspectives and current status of a versatile reagent introduced over 150 years ago at the University of Dorpat, Tartu, Estonia.<\/title><secondary-title>Die Pharmazie<\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.1691\/ph.2020.0438<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Chen Q<\/author><author>Chen W<\/author><author>Hao F<\/author><\/authors><\/contributors><titles><title>Cutaneous tuberculosis: A great imitator.<\/title><secondary-title>Clinics in dermatology<\/secondary-title><\/titles><dates><year>2019<\/year><\/dates><electronic-resource-num>10.1016\/j.clindermatol.2019.01.008<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Gremi\u00e3o ID<\/author><author>Menezes RC<\/author><author>Schubach TM et al.<\/author><\/authors><\/contributors><titles><title>Feline sporotrichosis: epidemiological and clinical aspects.<\/title><secondary-title>Medical mycology<\/secondary-title><\/titles><dates><year>2015<\/year><\/dates><electronic-resource-num>10.1093\/mmy\/myu061<\/electronic-resource-num><\/record>\n<\/records><\/xml>\n"

"\n\nMolGod<\/database>MOL-GOD<\/source-app>1<\/rec-number>17<\/ref-type>The Cancer Genome Atlas Network<\/author><\/authors><\/contributors>Comprehensive molecular portraits of human breast tumours<\/title><secondary-title>Nature<\/secondary-title><\/titles><dates><year>2012<\/year><\/dates><electronic-resource-num>10.1038\/nature11412<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.nature.com\/articles\/nature11412.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Boris T. Bikbov<\/author><author>Caroline A. Purcell<\/author><author>Andrew S. Levey et al.<\/author><\/authors><\/contributors><titles><title>Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017<\/title><secondary-title>The Lancet<\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.1016\/s0140-6736(20)30045-3<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.thelancet.com\/pdfs\/journals\/lancet\/PIIS0140-6736(20)30045-3.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Michel Bazinet<\/author><author>Victor P\u00e2ntea<\/author><author>Valentin Cebotarescu et al.<\/author><\/authors><\/contributors><titles><title>Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial<\/title><secondary-title>\u0098The \u009cLancet. Gastroenterology & hepatology<\/secondary-title><\/titles><dates><year>2017<\/year><\/dates><electronic-resource-num>10.1016\/s2468-1253(17)30288-1<\/electronic-resource-num><urls><related-urls><url>https:\/\/ibn.idsi.md\/vizualizare_articol\/56691<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>http:\/\/ljournal.ru\/wp-content\/uploads\/2017\/03\/a-2017-023.pdf<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2017<\/year><\/dates><electronic-resource-num>10.18411\/a-2017-023<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.18411\/a-2017-023<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Marissa Giustina<\/author><author>Marijn A. M. Versteegh<\/author><author>S\u00f6ren Wengerowsky et al.<\/author><\/authors><\/contributors><titles><title>Significant-Loophole-Free Test of Bell\u2019s Theorem with Entangled Photons<\/title><secondary-title>Physical Review Letters<\/secondary-title><\/titles><dates><year>2015<\/year><\/dates><electronic-resource-num>10.1103\/physrevlett.115.250401<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.1103\/physrevlett.115.250401<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Joppe W. Bos<\/author><author>L\u00e9o Ducas<\/author><author>Eike Kiltz et al.<\/author><\/authors><\/contributors><titles><title>CRYSTALS - Kyber: A CCA-Secure Module-Lattice-Based KEM<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1109\/eurosp.2018.00032<\/electronic-resource-num><urls><related-urls><url>https:\/\/ir.cwi.nl\/pub\/27896\/27896.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Annika Rosengren<\/author><author>Andrew Smyth<\/author><author>Sumathy Rangarajan et al.<\/author><\/authors><\/contributors><titles><title>Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study<\/title><secondary-title>The Lancet Global Health<\/secondary-title><\/titles><dates><year>2019<\/year><\/dates><electronic-resource-num>10.1016\/s2214-109x(19)30045-2<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.thelancet.com\/article\/S2214109X19300452\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Kyle J Foreman<\/author><author>Neal Marquez<\/author><author>Andrew J. Dolgert et al.<\/author><\/authors><\/contributors><titles><title>Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016\u201340 for 195 countries and territories<\/title><secondary-title>The Lancet<\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1016\/s0140-6736(18)31694-5<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.thelancet.com\/article\/S0140673618316945\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>The Cancer Genome Atlas Research Network<\/author><\/authors><\/contributors><titles><title>Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas<\/title><secondary-title>New England Journal of Medicine<\/secondary-title><\/titles><dates><year>2015<\/year><\/dates><electronic-resource-num>10.1056\/nejmoa1402121<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa1402121?articleTools=true<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Peter K\u00e4mpfer<\/author><author>P. D. Rekha<\/author><author>Peter Sch\u00fcmann et al.<\/author><\/authors><\/contributors><titles><title>Microbacterium arthrosphaerae sp. nov., isolated from the faeces of the pill millipede Arthrosphaera magna Attems<\/title><secondary-title>INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY<\/secondary-title><\/titles><dates><year>2010<\/year><\/dates><electronic-resource-num>10.1099\/ijs.0.026401-0<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Gregory M. Chin<\/author><author>Anne M. Villeneuve<\/author><\/authors><\/contributors><titles><title>C. elegans mre-11 is required for meiotic recombination and DNA repair but is dispensable for the meiotic G2 DNA damage checkpoint<\/title><secondary-title>Genes & Development<\/secondary-title><\/titles><dates><year>2001<\/year><\/dates><electronic-resource-num>10.1101\/gad.864101<\/electronic-resource-num><urls><related-urls><url>http:\/\/genesdev.cshlp.org\/content\/15\/5\/522.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Jake E. Thistle<\/author><author>Jessica L. Petrick<\/author><author>Baiyu Yang et al.<\/author><\/authors><\/contributors><titles><title>Domperidone use and risk of primary liver cancer in the Clinical Practice Research Datalink<\/title><secondary-title>Cancer Epidemiology<\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1016\/j.canep.2018.06.009<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/7008444<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Cullen T<\/author><author>Mullins J<\/author><author>Rambaud CT et al.<\/author><\/authors><\/contributors><titles><title>Making Vaccines Equitably Available to All Persons in Pima County, Arizona, 2020-2021.<\/title><secondary-title>American journal of public health<\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.2105\/AJPH.2022.307040<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/9558202<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Kusuhara M<\/author><\/authors><\/contributors><titles><title>[Sporotrichosis and dematiaceous fungal skin infections].<\/title><secondary-title>Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology<\/secondary-title><\/titles><dates><year>2009<\/year><\/dates><electronic-resource-num>10.3314\/jjmm.50.213<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.jstage.jst.go.jp\/article\/jjmm\/50\/4\/50_4_213\/_pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Aaseth J<\/author><author>Nurchi VM<\/author><author>Andersen O<\/author><\/authors><\/contributors><titles><title>Medical Therapy of Patients Contaminated with Radioactive Cesium or Iodine.<\/title><secondary-title>Biomolecules<\/secondary-title><\/titles><dates><year>2019<\/year><\/dates><electronic-resource-num>10.3390\/biom9120856<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.mdpi.com\/2218-273X\/9\/12\/856\/pdf?version=1576062311<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Angermayr L<\/author><author>Clar C<\/author><\/authors><\/contributors><titles><title>WITHDRAWN: Iodine supplementation for preventing iodine deficiency disorders in children.<\/title><secondary-title>The Cochrane database of systematic reviews<\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1002\/14651858.CD003819.pub3<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003819.pub3\/pdf\/full<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Burch HB<\/author><author>Cooper DS<\/author><\/authors><\/contributors><titles><title>Management of Graves Disease: A Review.<\/title><secondary-title>JAMA<\/secondary-title><\/titles><dates><year>2015<\/year><\/dates><electronic-resource-num>10.1001\/jama.2015.16535<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Raal A<\/author><author>Meos A<\/author><author>Hinrikus T et al.<\/author><\/authors><\/contributors><titles><title>Dragendorff's reagent: Historical perspectives and current status of a versatile reagent introduced over 150 years ago at the University of Dorpat, Tartu, Estonia.<\/title><secondary-title>Die Pharmazie<\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.1691\/ph.2020.0438<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Chen Q<\/author><author>Chen W<\/author><author>Hao F<\/author><\/authors><\/contributors><titles><title>Cutaneous tuberculosis: A great imitator.<\/title><secondary-title>Clinics in dermatology<\/secondary-title><\/titles><dates><year>2019<\/year><\/dates><electronic-resource-num>10.1016\/j.clindermatol.2019.01.008<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Gremi\u00e3o ID<\/author><author>Menezes RC<\/author><author>Schubach TM et al.<\/author><\/authors><\/contributors><titles><title>Feline sporotrichosis: epidemiological and clinical aspects.<\/title><secondary-title>Medical mycology<\/secondary-title><\/titles><dates><year>2015<\/year><\/dates><electronic-resource-num>10.1093\/mmy\/myu061<\/electronic-resource-num><\/record>\n<\/records><\/xml>\n"